Leerink Partners Reiterates Market Perform Rating on Boundless Bio Inc. (BOLD) following Q4 report, pipeline update
Tweet Send to a Friend
Leerink Partners analyst Andrew Berens reiterated a Market Perform rating and $4.00 price target on Boundless Bio Inc. (NASDAQ: BOLD)The ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
